Full Breakdown
Trump Administration Moves to Place Political Appointees on NIH Grant Decisions
By Drooid · · How we work
Core Event: Drafting of Executive Order to Create a Grant-Veto Committee
President Donald Trump directed Office of Management and Budget (OMB) Director Russell Vought to draft an executive order establishing an external committee with authority to veto NIH awards that do not align with the president’s agenda. The proposal was discussed in an Oval Office meeting on a Friday, according to two administration officials. If enacted, the committee could give political appointees final say over billions of dollars of NIH funding.
Background & Context
Trump’s second term has featured actions aimed at curbing “woke” influence in academia. An executive order on his first day back terminated federal programs focused on “diversity, equity and inclusion,” reshaping NIH funding for health-disparities research. The administration also sued Harvard University to block $2.6 billion in grant funding, alleging insufficient action on anti-Semitism; a federal judge restored the funding last year and the White House has lost two lawsuits since. Earlier this year, OMB proposed a rule to give political appointees greater authority to review and block grants deemed inconsistent with administration policy; Congress barred that rule in the September 2026 appropriations bill.
Key Figures & Groups
- President Donald Trump — seeking to expand control over NIH grants.
- Russell Vought — OMB director tasked with drafting the order.
- Jay Bhattacharya — NIH director resisting political interference.
- Joshua Pradko — NIH spokesperson.
- Harvard University — target of the funding challenge.
- American Civil Liberties Union (ACLU) — filed a class-action lawsuit alleging unconstitutional censorship of scientific research.
Timeline
- Friday (unspecified date) – Oval Office meeting where Trump, Vought, and Bhattacharya discussed the draft order.
- First day of Trump’s second term – Executive order ending DEI-related federal programs.
- Last year – Harvard sued; a federal judge ordered restoration of $2.6 billion in NIH grants.
- May 2026 – OMB proposed a rule to extend political review to all federal grant-making.
- September 2026 – Congress included a provision in the stopgap funding bill that temporarily blocks the earlier OMB plan.
Data & Statistics
- The NIH operates with an annual budget of $48 billion, distributing the majority to biomedical research labs nationwide.
- The Harvard lawsuit centered on $2.6 billion in existing NIH grant funding.
Official Statements & Responses
NIH spokesperson Joshua Pradko, responding by text, affirmed the agency’s mission: “NIH remains committed to its mission of funding biomedical research to benefit the health of the American people.” He also rejected reports of grant rescissions, stating, “There will be no rescissions to NIH grant monies. All NIH grant monies will be spent.”
Senate Appropriations Chair Susan Collins (R-ME) personally rejected Vought’s plan, and the September appropriations bill barred OMB from finalizing the earlier proposal.
Criticism & Opposition
Scientists, medical societies, and bipartisan members of Congress warn that the proposal would inject politics into the peer-review process that has traditionally guided NIH funding. Lawmakers and state attorneys general criticize the plan for threatening the integrity of biomedical research.
The ACLU filed a class-action lawsuit in a California district court on behalf of researchers studying health disparities, Alzheimer’s disease, and sexual harassment, alleging that NIH’s grant-screening measures violate the First Amendment by targeting “disfavored viewpoints.”